Lundbeck
Inside Development of Lundbeck’s Inhouse Global Compound Management and Compound Ordering System - An Interview with Claus Stie Kallesøe
February 12 by Gerald ClarkeCreating a fit-for-purpose compound management and compound ordering system is a huge task, so often the best way to understand is to look at those who have done it before. We spoke to Claus Stie Ka...
Reflections on Compound Management in an Ever-Changing Organisation
September 16 by Pharmaceuticals & Biotechnology EditorTenna Juul Schroder, Head of Department, Molecular Pharmacology, Lundbeck, shares her insights on compound management in an ever-changing organisation and discusses new compound management strategie...
Addressing the Commercial Importance of Supplementary Protection Certificates
August 16 by Andrea CharlesAs major patents on blockbuster drugs continue to expire, Chris Hayes, Senior Advisor, Intellectual Property Rights - Launched Products, Lundbeck, and Andrea Charles from Pharma IQ discuss how retur...
Stumbling Blocks for Patient Compliance in Parkinson’s Disease Treatment
May 12 by Helen WinsorNicolas Favre, International Brand Manager, Azilect at Lundbeck, joins Pharma IQ to discuss the commonly experienced patient adherence challenges for Parkinson’s Disease sufferers. He also...
3 Tips on Overcoming Poor Aqueous Solubility and Stability
February 15 by Helen WinsorWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Rene Holm, Head of Preformulation at H L...
How a Lean Approach to Pharma Can Lead to Positive Gains?
April 26 by Klaus Hjortgaard OlsenIt is very rare to diet and see instant results, but taking a lean approach to your department can produce quick visible gains. “Within the last 6 months we have seen an OEE increase of 25%...
Lundbeck's Jorrit Hornberg on the Latest Predictive Toxicology Developments
April 26 by Jorrit J. Hornberg, PhDJorrit Hornberg, Head of Section of In-vitro Studies in the Department of Exploratory Toxicology at Lundbeck, speaks to Andrea Charles from Pharma IQ, about the latest devlopments in predictive toxico...
Optimizing Solubilization of Lipid Formulations in the GI Tract
April 26 by René HolmWith the advent of improved techniques for drug discovery, there has been a transition towards new chemical entities to be hydrophobic and non-polar, which in turn has made solubilization of these e...
Working Effectively with a CRO
April 26 by Helle Aagaard-KirkebyIn this Pharma IQ interview Helle Aagaard-Kirkeby Primary Clinical Supply Manager, Clinical Supply Development, Lundbeck speaks to Pharma IQ about the key challenges that companies are facing in cli...